Up and Coming: Haoyang Li, Ph.D. – An Inspired Vaccine
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
The world goes crazy around you
The pace of research for La Jolla Institute for Immunology’s Coronavirus Task Force is intense. Samples come in, data come out. Some labs are running 24-7. LJI scientists have brought us closer to ending the pandemic. They’ve also missed months of family dinners and bedtime stories. Missed sleep. Missed the before days. This is the story—in the researchers’ own words—of how LJI’s dedicated scientists took on COVID-19.
Daniela Weiskopf Awarded $1.4 million to Study COVID-19 in Latino Americans
LA JOLLA, CA—Latino Americans have been hit very hard by the COVID-19 pandemic. In fact, the U.S. Centers for Disease
How Pandemics End
Nearly every pandemic has had an arc. A disease spreads, it kills, it stops. We don’t yet know how the
Letter from the President – Fall 2020
As I write this, several promising vaccine candidates are advancing through clinical trials. This pandemic will end through the development of vaccines, better treatments for people who are ill, and responsible social behavior.
Every COVID-19 case seems different. These scientists want to know why.
LA JOLLA—As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
Researchers tracking COVID-19 mortality early in the pandemic noticed that some countries had a significantly lower mortality rate than others.
A step toward helping patients breathe deeply
LA JOLLA—Your lungs and airways need to be stretchy, sort of like balloons. Take a big breath, and they’ll open
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
LA JOLLA, CA—Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more
LJI scientists receive $3.5 million to investigate role of immune cells in Parkinson’s disease
LA JOLLA—Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
Blocking nerve signals to the pancreas halts type 1 diabetes onset in mice
LA JOLLA—Your pancreas is a little sweet potato-shaped organ that sits snug behind your stomach. The pancreas is studded with